HK1251250A1 - 作為腸道菌群的益生基礎菌種的雙歧桿菌 - Google Patents
作為腸道菌群的益生基礎菌種的雙歧桿菌Info
- Publication number
- HK1251250A1 HK1251250A1 HK18110521.7A HK18110521A HK1251250A1 HK 1251250 A1 HK1251250 A1 HK 1251250A1 HK 18110521 A HK18110521 A HK 18110521A HK 1251250 A1 HK1251250 A1 HK 1251250A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- bifidobacteria
- probiotic
- gut microbiota
- foundation
- species
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2015/082887 WO2017000249A1 (en) | 2015-06-30 | 2015-06-30 | Bifidobacteria as probiotic foundation species of gut microbiota |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1251250A1 true HK1251250A1 (zh) | 2019-01-25 |
Family
ID=57607443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18110521.7A HK1251250A1 (zh) | 2015-06-30 | 2018-08-16 | 作為腸道菌群的益生基礎菌種的雙歧桿菌 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20180177833A1 (zh) |
CN (1) | CN107849519A (zh) |
HK (1) | HK1251250A1 (zh) |
MY (1) | MY187060A (zh) |
TW (1) | TWI594758B (zh) |
WO (1) | WO2017000249A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11607435B2 (en) * | 2017-02-10 | 2023-03-21 | Perfect (China) Co., Ltd. | Probiotics Bifidobacteria strains |
EP3773645A4 (en) * | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | MICROBIAL CONSORTIA |
WO2019227414A1 (zh) * | 2018-05-31 | 2019-12-05 | 深圳华大生命科学研究院 | 一种组合物及其应用 |
CN110093286B (zh) * | 2019-03-19 | 2021-12-17 | 江南大学 | 假小链双歧杆菌ccfm1046、其组合物、发酵食品、用途、菌剂及其菌剂制备方法 |
CN110106103B (zh) * | 2019-03-19 | 2022-05-03 | 江南大学 | 假小链双歧杆菌ccfm1047、其组合物、发酵食品、用途、菌剂及其菌剂制备方法 |
CN110106104B (zh) * | 2019-03-19 | 2021-12-17 | 江南大学 | 假小链双歧杆菌ccfm1048、其组合物、发酵食品、用途、菌剂及其菌剂制备方法 |
CN110093287B (zh) * | 2019-03-19 | 2022-05-20 | 江南大学 | 假小链双歧杆菌ccfm1045、其组合物、发酵食品、用途、菌剂及其菌剂制备方法 |
US20220395551A1 (en) | 2019-12-06 | 2022-12-15 | Keni Nii | Compositions and applications with functions to improve the diversity of personalized intestinal flora |
CN110894481B (zh) * | 2019-12-09 | 2023-06-27 | 毕德玺 | 一株假链状双歧杆菌及其应用 |
CN111588021A (zh) * | 2020-05-25 | 2020-08-28 | 北京科拓恒通生物技术股份有限公司 | 一株可缓解和治疗冠心病的乳双歧杆菌Probio-M8及其应用 |
CN111979145B (zh) * | 2020-08-07 | 2022-06-28 | 上海交通大学 | 人源的粘膜乳杆菌及其用途 |
CN113122471B (zh) * | 2021-04-06 | 2022-08-23 | 江南大学 | 一株高利用低聚半乳糖的假小链双歧杆菌及其应用 |
WO2023149907A1 (en) * | 2022-02-07 | 2023-08-10 | Seed Health Inc. | Methods of synbiotic treatment to improve health |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19826928A1 (de) * | 1998-06-17 | 1999-12-23 | Novartis Consumer Health Gmbh | Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen |
BRPI0418986A (pt) * | 2004-08-05 | 2007-12-11 | Anidral Srl | cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos |
CA2591668A1 (en) * | 2004-12-14 | 2006-06-22 | Alk-Abello A/S | Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound |
FR2920304B1 (fr) * | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
FI20096402A0 (fi) * | 2009-12-28 | 2009-12-28 | Suomen Punainen Risti Veripalv | Veriryhmästatuksen käyttö II |
ES2389547B1 (es) * | 2010-12-07 | 2013-08-08 | Consejo Superior De Investigaciones Científicas (Csic) | Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas. |
GB201112091D0 (en) * | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
CN104413334A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 可食用组合物及其制备方法和用途 |
-
2015
- 2015-06-30 CN CN201580081342.3A patent/CN107849519A/zh active Pending
- 2015-06-30 US US15/738,122 patent/US20180177833A1/en not_active Abandoned
- 2015-06-30 MY MYPI2017704927A patent/MY187060A/en unknown
- 2015-06-30 WO PCT/CN2015/082887 patent/WO2017000249A1/en active Application Filing
-
2016
- 2016-06-30 TW TW105120709A patent/TWI594758B/zh active
-
2018
- 2018-08-16 HK HK18110521.7A patent/HK1251250A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017000249A1 (en) | 2017-01-05 |
TW201703778A (zh) | 2017-02-01 |
TWI594758B (zh) | 2017-08-11 |
CN107849519A (zh) | 2018-03-27 |
MY187060A (en) | 2021-08-28 |
US20180177833A1 (en) | 2018-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251250A1 (zh) | 作為腸道菌群的益生基礎菌種的雙歧桿菌 | |
IL287789A (en) | Mogroside compounds, methods for their preparation, preparations including them and their uses | |
HRP20192145T1 (hr) | Pripravci nosača-antitijela i metode pripreme i uporabe istih | |
IL254016A0 (en) | A preparation for medical and preventive treatment produced by microbiota | |
IL249982A0 (en) | Oligosaccharide compounds and methods of producing them | |
GB2546350B (en) | Compositions and methods | |
PL3307289T3 (pl) | Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt) | |
ZA201803451B (en) | Probiotic compositions and uses thereof | |
IL259246A (en) | Preparations containing pharmaceutical substances and methods of using them | |
ZA201702794B (en) | Cellulose-containing compositions and methods of making same | |
IL259888B (en) | Method of lyophilization of a sample of faecal microbiota | |
GB201718876D0 (en) | Antithrombin-heparin compositions and methods | |
IL251120A0 (en) | Immunogenic/therapeutic glycoside preparations and their uses | |
IL263218A (en) | Compounds and methods for microbiotic therapy | |
IL256833A (en) | il-17f trapping materials - specifics, preparations and methods for use and preparation | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
GB201400431D0 (en) | Phospholipid compositions and their preparation | |
GB201501938D0 (en) | Probiotic preparation | |
HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
EP3253396A4 (en) | Probiotic compositions and methods of use | |
GB201512996D0 (en) | Compositions and methods | |
GB201509023D0 (en) | Compositions and methods of production thereof | |
SG11201608250YA (en) | Polymer powder composition and its method of preparation | |
GB201514413D0 (en) | Compositions and methods | |
IL256261B (en) | Hide1 compositions and methods |